Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on serum lactate levels in cardiac surgery
IRCT20240802062618N1Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in coronary arteriosclerosis, aortic valve disease (AVD) and mitral valve disease, sponsored by Rajaie Cardiovascular Medical and Research Center. Primary endpoint: Change in serum lactate levels. Started Nov 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosisaortic valve disease (AVD)mitral valve disease
Beyond the preview
Go deeper on IRCT20240802062618N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240802062618N1.